National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction

Authors:

Abstract
DESPITE THE IMPORTANCE of β-blockers for secondary prevention after acute myocardial infarction (AMI),1,2 several studies have suggested that they are substantially underutilized,3-10 particularly in older patients. Although these studies agree that increasing the appropriate use of β-blockers is an important opportunity to improve secondary prevention after an AMI, they differ in study design and approach, yielding very different estimates of the use of β-blockers. None provide a national perspective on the prescribed use of β-blockers after an AMI in the treatment of elderly patients. The studies that have linked patterns of use of β-blockers with outcomes have been restricted to very selected samples7 or have been dependent on claims databases for clinical information9 but generally have found that β-blockers are associated with increased survival.

This publication has 9 references indexed in Scilit: